Rx Rundown: Johnson & Johnson, Eli Lilly, the FDA and more
Deals: Johnson & Johnson announced it will buy Intra-Cellular Therapies for $14.6 billion. Biogen said it will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22 apiece. Eli Lilly is set to acquire Scorpion …